Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP & Number of Procedure Conducted by Product Type, Application & End-User The global soft tissue repair market size was $12.62 billion in 2021 and is predicted to reach $22.84 billion by 2030, representing a CAGR of 6.81% throughout the period of 2021-2030. The region of North America significantly held the largest market share of about 43.5% & is also the fastest-growing market for soft tissue repair. The soft tissue repair process replaces injured or damaged tissues with healthy ones (Angiogenesis and Fibroplasia) with the epithelialization process. Methods such as Allografts, xenografts, and Electrotherapy, which have a poor success rate, are now the most common therapeutic choices. As a result, superior, technologically sophisticated options, such as less invasive treatments and quick-healing solutions, are essential. Muscles, tendons, and ligaments containing CNS and non-CNS tissues often suffer from soft tissue injuries, which cause discomfort, contraction, and inflammation. According to Johns Hopkins University's study, about 30 million children and teens in the United States participate in organized sports. Every year, around 3.5 million injuries occur, resulting in time away from the sport. This is further going to fuel the growth of the soft tissue repair market. Market Drivers A rise in the geriatric population, the increase of sport-related injuries, the rise in cosmetic surgeries, and increasing severe trauma injuries Pressure ulcers, venous stasis ulcers, & other chronic lesions are more common in the geriatric population. According to the Advances in Orthopaedic Surgery journal study, a rotator cuff injury affects more than 40% of the population aged 60 and more. The increasing geriatric population means that there will be an increase in the demand of orthopaedic surgeries which will drive the market growth. The effects of sports and physical activities on one's health are becoming better recognized across the world. The rise in sports Injuries like Ankle Sprain, Muscle Strain Injuries of the Hip, soft tissue repair surgery, Tendonitis, Bursitis, Stress injuries because of the youth's interest in sports has grown as a result of this. Sports are also gaining popularity in Asian nations such as China, Korea, India, and the countries of the former Soviet Union. According to the NFHSA (National Federation of State High School Associations) High School Athletics Participation Survey, the number of high school sports participants grew for the 25th year in a row in 2020–2021. Increasing sports participation will result in the rise of sports-related injuries, thus driving the overall market growth extensively. In aesthetic & reconstructive plastic surgery, soft tissue repair items such as tissue and grafts, and suture anchors play an important role. The American Society of Plastic Surgeons successfully released its yearly plastic surgery procedural statistics, reporting that 1.8 Mn surgical cosmetic procedures and 15.9 Mn minimally invasive cosmetic procedures were performed in the USA in 2020 representing a 2% and 1% increase over 2017. During the same time, 5.8 Mn reconstructive surgeries were conducted in the United States. Hence, the increasing demand for cosmetic surgery is driving the overall market. TBIs, spinal cord injuries, spine fractures, collapsed lungs, and subarachnoid haemorrhages are some of the severe trauma injuries for which soft tissue repair products are being used. The Centers for Disease Control & Prevention (CDC), asserted that TBIs caused around 61,000 injury-related fatalities in the United States in 2019, or roughly 166 deaths every day. The rising frequency of trauma injuries, including TBIs and injuries from falls and accidents, is predicted to increase the number of trauma operations done worldwide. During the forecast period, this is a crucial factor for the overall market growth. Restraints Issues with reimbursement The industry trend is being stifled by unfavourable reimbursement policies in most countries worldwide. According to Science Direct, from 2011 to 2021, the overall national inflation rate was around 16.3%. The Unadjusted reimbursement policy rates for open & laparoscopic inguinal hernia repairs surged by 6.5% & 7.2%, respectively. There was also an increase in the unadjusted reimbursements for the open appendectomies of 5.1% & 6.1% in the case laparoscopic. When it was adjusted to 2021 values, it was found that the reimbursements for all of the six operations decreased out of which, the laparoscopic & open cholecystectomies experienced the largest decreases (i.e..19.8%, & 10.2%). Opportunities An increase in the use of soft tissue healing solutions in emerging markets, Support from Government agencies Countries like China, India, and Brazil are projected to offer many development possibilities for participants in the orthopedic soft tissue repair market. This is due to a huge patient population for target indications (cardiovascular and soft tissue repair patches, orthopaedic, general/abdominal, and gynaecological problems), expanding health awareness, rising healthcare expenditure, and increasing medical tourism, and fast building healthcare infrastructure in these nations. A study of the Global burden of Disease suggests that cardiovascular disorders are presently India's top cause of death. Heart disease and stroke were responsible for roughly 80% of the healthcare burden in India in 2020, accounting for around 25% of all fatalities. Governments of various Asian Pacific countries are launching steps to improvise their healthcare systems. About 1.35 billion individuals enrolled in the basic medical insurance programme due to China's healthcare reforms and the 13th Five-Year Plan, accounting for roughly 95 per cent of the country's population. According to World Bank 2020 estimates, In Latin America, healthcare expenditure climbed to roughly 7.93 per cent of total GDP in 2019 from about 6.53 per cent of total GDP in 2002. Soft tissue healing has become more accessible in emerging nations due to these improvements. As a result, many worldwide market competitors are concentrating their efforts on gaining a larger part of the rising market. Major companies in the APAC area are taking advantage of the region's expanding market potential. Soft Tissue Repair Market Analysis Of Different Segments The industry segmentation is based on Product, Application, End-user, and Region. Based on Product Tissue patch/mash Laparoscopic instrument injectors Allograft Xenograft Suture Anchor Interference Screws Based on Application Hernia Repair Dural Repair Vaginal Sling Procedures Skin Repair Orthopaedic repair Dental repair Breast Reconstruction Repair Based on the End-user Hospitals Clinics Other end-users Based on Region North America USA Canada Mexico Rest of North America Europe UK Germany Russia Poland Finland Italy Rest of Europe Asia Pacific India China Japan Rest of APAC LAMEA UAE Argentina Brazil Rest of LAMEA Based on the Product, Tissue Patch/Mesh segment held the largest industry share of 91.9%. The growing usage of synthetic Mesh in various orthopaedic procedures due to its ability to minimize surgery time accounts for a substantial portion of this market. According to the Arthritis Foundation, around 30.8 million adults in the United States were diagnosed with arthritis in 2019, and 14 million people in the United States were diagnosed with symptomatic knee osteoarthritis. Based on the Application, The Hernia repair segment has the largest market share of around 26.5% due to the rising prevalence of hernia cases, sports injuries, and lifestyle conditions such as arthritis, osteoporosis, and obesity (which can lead to orthopaedic difficulties) are all contributing to the rise in the number of soft tissue repair procedures conducted across the world. According to the FDA, more than 800,000 hernia repair operations are performed in the United States each year. As a result of the increased frequency of these surgical operations, hernia repair devices are in great demand. Based on End Users, the Hospital segment held the largest share of 93.9% in 2020. This is due to the expanding elderly population and the prevalence of numerous ailments, resulting in an increase in the operations performed throughout the world. Based on Regions, North America has the largest soft tissue repair market share of 43.5% and is the fastest-growing market for soft tissue repair. The existence of an advanced healthcare system in the region, as well as a high and rising number of surgical operations, increased adoption of innovative goods, and the presence of numerous prominent market players in the US, are all factors that contribute to the region's substantial share of the market. Report Attribute Details Forecast Period 2021 - 2030 Market size value in 2021 USD 12.62 billion Revenue forecast in 2030 USD 22.84 billion Growth rate CAGR of approximately 6.81% Base year for estimation 2021 Unit USD Billion, CAGR (2021 - 2030) Segmentation By Product, By Application, By End-User, By Region By Product Tissue patch/mash, Laparoscopic instrument injectors By Application Hernia Repair, Dural Repair, Vaginal Sling Procedures, Skin Repair, Orthopaedic repair, Dental repair, Breast Reconstruction Repair By End-User Hospitals, Clinics, and Other end-users By Region Asia Pacific, North America, Europe, LAMEA Country Scope U.S., Canada, France, Germany, U.K., China, Japan, India, South Korea, Mexico, Brazil, U.A.E. etc. Company Usability Profiles Smith & Nephew Plc., Arthrex, Inc., Stryker Corporation, Johnson & Johnson, Medtronic Plc., LifeNet Health, Inc., Becton, Dickinson and Company, Integra LifeSciences Corporation, CryoLife, Inc., Organogenesis Inc., Zimmer Biomet, Baxter International, Inc., ACell Inc., Tissue Regenix Group Plc, Aroa Biosurgery Ltd., and Orthofix Medical Inc. Competitive Landscape Analysis The competitive landscape analysis provides information about the crucial competitors prevailing in the worldwide market environment. The comparison is performed based on overall revenue generation, market initiatives, company overview, investment in R&D, company financials, company strengths and weaknesses, global presence, production capacity, production sites and facilities, market potential, etc. The key players that are included in the industry are: Smith & Nephew Plc. (UK) Arthrex, Inc. (US) Stryker Corporation (US) Johnson & Johnson (US) Medtronic Plc. (IE) LifeNet Health, Inc. (US) Becton, Dickinson and Company (US) Integra LifeSciences Corporation (US) CryoLife, Inc. (US) Organogenesis Inc. (US) Zimmer Biomet (US) Baxter International, Inc. (US) ACell Inc. (US) In2Bones (US) Tissue Regenix Group Plc (UK) Aroa Biosurgery Ltd. (NZ) Orthofix Medical Inc. Recent Developments On August 2022, Avita Medical, an US based company announced the final results of a trial that it had conducted in the patients suffering from soft tissue injuries using its newly launched RECELL System. This system has been uniquely integrated with a meshed autograft to reduce the donor-skin harvesting in the process of soft-tissue reconstruction. The trial results showed that the RECELL System has successfully cured some of the most deadly flesh eating diseases, surgical wounds, and serious skin injuries. In December 2020, ACell was purchased for $300 million by Integra Lifesciences, a medical device business located in the United States. The deal is intended to boost Integra Lifesciences' tissue regeneration capabilities while also complementing the company's current tissue technologies portfolio. In October 2020, The O-GENESIS Graft Delivery System and AlloQuent Structural Allograft Q-Pack, ready-to-use cervical and lumbar spacers for allograft surgeries, were launched by Orthofix Medical Inc. in the United States. In April 2020, The ClearGuard LE Endoscopic Soft Tissue Release System, which orthopaedic and podiatric specialists use to treat a variety of foot problems, was launched in the United States by In2Bones, a US-based designer, manufacturer, and distributor of medical devices for the treatment of disorders and injuries. For high-volume lower extremity, soft tissue procedures such as plantar fascia, gastrocnemius, tarsal tunnel, and Morton's neuroma, the ClearGuard LE Endoscopic Soft Tissue Release Technology provides orthopaedic and podiatric experts with an easy-to-use, reproducible, and cost-effective system. In February 2020, Peri-Strips Dry with Veritas Collagen Matrix with Secure Grip received FDA 510(k) approval from Baxter. The product is a reinforcing agent used to prevent bleeding during bariatric and other surgical operations. In February 2020, The AmnioExcel Plus Placental Allograft Membrane was launched by Integra LifeSciences Holdings Corp. for use in soft-tissue repair. Various devices that the market leaders are manufacturing are: Name of the Product Function Key Players AlloQuent Structural Allograft Q-Pack And O-GENESIS Graft Delivery System Ready-to-use cervical and lumbar spacers for allograft surgeries Orthofix Medical Inc. AmnioExcel Plus Used in soft-tissue repair Integra LifeSciences Holdings Corp ClearGuard LE Endoscopic To treat a variety of foot problems In2Bones Peri-Strips Dry Reinforcing agent used to prevent bleeding during surgeries Baxter Frequently Asked Question About This Report What are the most dominant regions of the global market? Based on regions, north america has the largest market for soft tissue repair with a share of 43.5%. The existence of an advanced healthcare system in the region, as well as a high and rising number of surgical operations, increased adoption of innovative goods, and the presence of numerous prominent market players in the US, are all factors that contribute to the regions substantial share of the market. How big is the soft tissue repair market? The global soft tissue repair market size was $12.62 Bn in 2021 and is predicted to reach $22.84 Bn by 2030, with a CAGR of 6.81%. The essential players in the Market? The most vital players in the industry are Smith & Nephew Plc., Arthrex, Inc., Stryker Corporation, Johnson & Johnson, Medtronic Plc., LifeNet Health, Inc., Becton, Dickinson and Company, Integra LifeSciences Corporation, CryoLife, Inc., Organogenesis Inc., Zimmer Biomet, Baxter International, Inc., ACell Inc., Tissue Regenix Group Plc, Aroa Biosurgery Ltd., and Orthofix Medical Inc. Which is the most dominant segment of the market based on end-users? On the basis of end users, the hospital segment held the largest share of 93.9% in 2020. What is the soft tissue repair market growth? The global soft tissue repair market is expected to grow at a compound annual growth rate (CAGR) of 6.81% from 2021 to 2030 to reach USD22.84 billion by 2030. . 1. Introduction 1.1. Study Objective 1.2. Market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. Market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size by Top-Down Analysis 2.5. Market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Market: Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 Market Summary 4. Industry Outlook 4.1 Market Snapshot 4.2 Global Soft Tissue Repair Market 4.2.1 Global market, 2021 – 2030 (USD Million) 4.3 Regional Business Analysis 4.3.1 Global market, by region, 2021-2030 (USD Million) 4.4 By Product Business Analysis 4.4.1 Global market, By Product, 2021-2030 (USD Million) 4.5 By End-User Business Analysis 4.5.1 Global market, By End-User, 2021-2030 (USD Million) 4.6 Application Business Analysis 4.6.1 Global market, By Application, 2021-2030 (USD Million) 4.7 Value Chain Analysis 4.8 Market Variable Analysis 4.8.1 Market Drivers Analysis 4.8.2 Market Restraints Analysis 4.9Business Environment Analysis Tool 4.9.1 market PEST analysis 4.9.2 market Porter’s analysis 4.10Penetration & Growth Prospect Mapping 5. Market Dynamics 5.1. Introduction 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 On Market 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. Application Analysis 5.11.1. Trends in Application (2014-2020) 5.11.2. Trends in Application (2021-2028) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By region, By Countries) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturers Manufacturing Sites, Area Served, Product Product 6.3. Market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Global Market: By Product Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. Tissue patch/mash 7.3.1. Tissue patch/mash market, 2021-2030 (USD Million) 7.4. Laparoscopic instrument injectors 7.4.1. Laparoscopic instrument injectors market, 2021-2030 (USD Million) 8. Global Market: By End-User Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. Hospitals 8.3.1. Hospitals market, 2021-2030 (USD Million) 8.4. Clinics 8.4.1. Clinics market, 2021-2030 (USD Million) 8.5. Other end-users 8.5.1. Other end-users market, 2021-2030 (USD Million) 9. Global Market: By Application Segment Analysis 9.1. Introduction 9.2. Sales Volume & Revenue Analysis (2021-2030) 9.3. Hernia Repair 9.3.1. Hernia Repair market, 2021-2030 (USD Million) 9.4. Dural Repair 9.4.1. Dural Repair market, 2021-2030 (USD Million) 9.5. Vaginal Sling Procedures 9.5.1. Vaginal Sling Procedures market, 2021-2030 (USD Million) 9.6. Skin Repair 9.6.1. Skin Repair market, 2021-2030 (USD Million) 9.7. Orthopaedic repair 9.7.1. Orthopaedic repair market, 2021-2030 (USD Million) 9.8. Dental repair 9.8.1. Dental repair market, 2021-2030 (USD Million) 9.9. Breast Reconstruction Repair 9.9 .1. Breast Reconstruction Repair market, 2021-2030 (USD Million) 10. Global Market: Regional Outlook 10.1 North America 10.1.1. North America market, by By Product, 2021-2030 (USD Million) 10.1.2. North America market, by By End-User, 2021-2030 (USD Million) 10.1.3. North America market, by Application, 2021-2030 (USD Million) 10.1.4. North America market, by Country, 2021-2030 (USD Million) 10.1.4.1. U.S. 10.1.4.1.1. U.S. market, by By Product, 2021-2030 (USD Million) 10.1.4.1.2. U.S. market, by By End-User, 2021-2030 (USD Million) 10.1.4.1.3. U.S. market, by Application, 2021-2030 (USD Million) 10.1.4.2.Canada 10.1.4.2.1. Canada market, by By Product, 2021-2030 (USD Million) 10.1.4.2.2. Canada market, by By End-User, 2021-2030 (USD Million) 10.1.4.2.3. Canada market, by Application, 2021-2030 (USD Million) 10.2. Europe 10.2.1. Europe market, by By Product, 2021-2030 (USD Million) 10.2.2. Europe market, by By End-User, 2021-2030 (USD Million) 10.2.3. Europe market, by Application, 2021-2030 (USD Million) 10.2.4. Europe market, by country, 2021-2030 (USD Million) 10.2.4.1 U.K. 10.2.4.1.1. U.K. market, by By Product, 2021-2030 (USD Million) 10.2.4.1.2. U.K. market, by By End-User, 2021-2030 (USD Million) 10.2.4.1.3. U.K. market, by Application, 2021-2030 (USD Million) 10.2.4.2. Germany 10.2.4.2.1. Germany market, by By Product, 2021-2030 (USD Million) 10.2.4.2.2. Germany market, by By End-User, 2021-2030 (USD Million) 10.2.4.2.3. Germany market, by Application, 2021-2030 (USD Million) 10.2.4.3. France 10.2.4.3.1. France market, by By Product, 2021-2030 (USD Million) 10.2.4.3.2. France market, by By End-User, 2021-2030 (USD Million) 10.2.4.3.3. France market, by Application, 2021-2030 (USD Million) 10.2.4.4. Rest of Europe 10.2.4.4.1. Rest of Europe market, by By Product, 2021-2030 (USD Million) 10.2.4.4.2. Rest of Europe market, by By End-User, 2021-2030 (USD Million) 10.2.4.4.3. Rest of Europe market, by Application, 2021-2030 (USD Million) 10.3. Asia Pacific 10.3.1. Asia Pacific market, by By Product, 2021-2030 (USD Million) 10.3.2. Asia Pacific market, by By End-User, 2021-2030 (USD Million) 10.3.3. Asia Pacific market, by Application, 2021-2030 (USD Million) 10.3.4. Asia Pacific market, by country, 2021-2030 (USD Million) 10.3.4.1. China 10.3.4.1.1. China market, by By Product, 2021-2030 (USD Million) 10.3.4.1.2. China market, by By End-User, 2021-2030 (USD Million) 10.3.4.1.3. China market, by Application, 2021-2030 (USD Million) 10.3.4.2. India 10.3.4.2.1. India market, by By Product, 2021-2030 (USD Million) 10.3.4.2.2. India market, by By End-User, 2021-2030 (USD Million) 10.3.4.2.3. India market, by Application, 2021-2030 (USD Million) 10.3.4.3. Japan 10.3.4.3.1. Japan market, by By Product, 2021-2030 (USD Million) 10.3.4.3.2. Japan market, by By End-User, 2021-2030 (USD Million) 10.3.4.3.3. Japan market, by Application, 2021-2030 (USD Million) 10.3.4.4. South Korea 10.3.4.4.1. South Korea market, by By Product, 2021-2030 (USD Million) 10.3.4.4.2. South Korea market, by By End-User, 2021-2030 (USD Million) 10.3.4.4.3. South Korea market, by Application, 2021-2030 (USD Million) 10.3.4.5. Rest of ASIA PACIFIC 10.3.4.5.1. Rest of ASIA PACIFIC market, by By Product, 2021-2030 (USD Million) 10.3.4.5.2. Rest of ASIA PACIFIC market, by By End-User, 2021-2030 (USD Million) 10.3.4.5.3. Rest of ASIA PACIFIC market, by Application, 2021-2030 (USD Million) 10.4. Latin America 10.4.1. Latin America market, by By Product, 2021-2030 (USD Million) 10.4.2. Latin America market, by By End-User, 2021-2030 (USD Million) 10.4.3. Latin America market, by Application, 2021-2030 (USD Million) 10.4.4. Latin America market, by country, 2021-2030 (USD Million) 10.4.4.1. Brazil 10.4.4.1.1. Brazil market, by By Product, 2021-2030 (USD Million) 10.4.4.1.2. Brazil market, by By End-User, 2021-2030 (USD Million) 10.4.4.1.3. Brazil market, by Application, 2021-2030 (USD Million) 10.4.4.2. Mexico 10.4.4.2.1. Mexico market, by By Product, 2021-2030 (USD Million) 10.4.4.2.2. Mexico market, by By End-User, 2021-2030 (USD Million) 10.4.4.2.3. Mexico market, by Application, 2021-2030 (USD Million) 10.4.4.3. Rest of the Latin America 10.4.4.3.1. Rest of the Latin America market, by By Product, 2021-2030 (USD Million) 10.4.4.3.2. Rest of the Latin America market, by By End-User, 2021-2030 (USD Million) 10.4.4.3.3. Rest of the Latin America market, by Application, 2021-2030 (USD Million) 10.5. MEA 10.5.1. MEA market, by By Product, 2021-2030 (USD Million) 10.5.2. MEA market, by By End-User, 2021-2030 (USD Million) 10.5.3. MEA market, by Application, 2021-2030 (USD Million) 10.5.4. MEA market, by Region, 2021-2030 (USD Million) 11. Competitive Landscape 11.1 Smith & Nephew Plc. (UK) 11.1.1. Company overview 11.1.2. Financial performance 11.1.3. ProductPortfolio Analysis 11.1.4. Business Strategy & Recent Development 11.2. ARTHREX, INC. (US) 11.2.1. Company overview 11.2.2. Financial performance 11.2.3. Product Portfolio Analysis 11.2.4. Business Strategy & Recent Development 11.3. STRYKER CORPORATION (US) 11.3.1. Company overview 11.3.2. Financial performance 11.3.3. Product Portfolio Analysis 11.3.4. Business Strategy & Recent Development 11.4. JOHNSON & JOHNSON (US) 11.4.1. Company overview 11.4.2. Financial performance 11.4.3. Product Portfolio Analysis 11.4.4. Business Strategy & Recent Development 11.5. MEDTRONIC PLC. (IE) 11.5.1. Company overview 11.5.2. Financial performance 11.5.3. Product Portfolio Analysis 11.5.4. Business Strategy & Recent Development 11.6. LifeNet Health, Inc. (US) 11.6.1. Company overview 11.6.2. Financial performance 11.6.3. Product Portfolio Analysis 11.6.4. Business Strategy & Recent Development 11.7. Becton, Dickinson and Company (US) 11.7.1. Company overview 11.7.2. Financial performance 11.7.3. Product Portfolio Analysis 11.7.4. Business Strategy & Recent Development 11.8. Integra LifeSciences Corporation (US) 11.8.1. Company overview 11.8.2. Financial performance 11.8.3. Product Portfolio Analysis 11.8.4. Business Strategy & Recent Development 11.9. CryoLife, Inc. (US) 11.9.1. Company overview 11.9.2. Financial performance 11.9.3. Product Portfolio Analysis 11.9.4. Business Strategy & Recent Development 11.10. Organogenesis Inc. (US) 11.10.1. Company overview 11.10.2. Financial performance 11.10.3. Product Portfolio Analysis 11.10.4. Business Strategy & Recent Development 11.11. Zimmer Biomet (US) 11.11.1. Company overview 11.11.2. Financial performance 11.11.3. Product Portfolio Analysis 11.11.4. Business Strategy & Recent Development 11.12. Baxter International, Inc. (US) 11.12.1. Company overview 11.12.2. Financial performance 11.12.3. Product Portfolio Analysis 11.12.4. Business Strategy & Recent Development 11.13. ACell Inc. (US) 11.13.1. Company overview 11.13.2. Financial performance 11.13.3. Product Portfolio Analysis 11.13.4. Business Strategy & Recent Development 11.14. Tissue Regenix Group Plc (UK) 11.14.1. Company overview 11.14.2. Financial performance 11.14.3. Product Portfolio Analysis 11.14.4. Business Strategy & Recent Development 11.15. AroaBiosurgery Ltd. (NZ) 11.15.1. Company overview 11.15.2. Financial performance 11.15.3. Product Portfolio Analysis 11.15.4. Business Strategy & Recent Development 11.16. Orthofix Medical Inc. 11.15.1. Company overview 11.15.2. Financial performance 11.15.3. Product Portfolio Analysis 11.15.4. Business Strategy & Recent Development List of Tables (64 Tables) TABLE 1. MARKET, By Product, 2021-2030 (USD Million) TABLE 2. MARKET FOR Tissue patch/mash, BY REGION, 2021-2030 (USD Million) TABLE 3. MARKET FOR Laparoscopic instrument injectors, BY REGION, 2021-2030 (USD Million) TABLE 4. MARKET, By End-User, 2021-2030 (USD Million) TABLE 5. MARKET FOR Hospitals, BY REGION, 2021-2030 (USD Million) TABLE 6. MARKET FOR Clinics, BY REGION, 2021-2030 (USD Million) TABLE 7. MARKET FOR Other end-users, BY REGION, 2021-2030 (USD Million) TABLE 8. MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 9. MARKET FOR Hernia Repair, BY REGION, 2021-2030 (USD Million) TABLE 10. MARKET FOR Dural Repair, BY REGION, 2021-2030 (USD Million) TABLE 11. MARKET FOR Vaginal Sling Procedures, BY REGION, 2021-2030 (USD Million) TABLE 12. MARKET FOR Skin Repair, BY REGION, 2021-2030 (USD Million) TABLE 13. MARKET FOR Orthopaedic repair, BY REGION, 2021-2030 (USD Million) TABLE 14. MARKET FOR Dental repairr, BY REGION, 2021-2030 (USD Million) TABLE 15. MARKET FOR Breast Reconstruction Repair, BY REGION, 2021-2030 (USD Million) TABLE 16. MARKET, BY REGION, 2021-2030 (USD Million) TABLE 17. NORTH AMERICA MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 18. NORTH AMERICA MARKET, By Product, 2021-2030 (USD Million) TABLE 19. NORTH AMERICA MARKET, By End-User, 2021-2030 (USD Million) TABLE 20. NORTH AMERICA MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 21. EUROPE MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 22. EUROPE MARKET, By Product, 2021-2030 (USD Million) TABLE 23. EUROPE MARKET, By End-User, 2021-2030 (USD Million) TABLE 24. EUROPE MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 25. ASIA-PACIFIC MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 26. ASIA-PACIFIC MARKET, By Product, 2021-2030 (USD Million) TABLE 27. ASIA-PACIFIC MARKET, By End-User, 2021-2030 (USD Million) TABLE 28. ASIA-PACIFIC MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 29. LAMEA MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 30. LAMEA MARKET, By Product, 2021-2030 (USD Million) TABLE 31. LAMEA MARKET, By End-User, 2021-2030 (USD Million) TABLE 32. LAMEA MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 33. Smith & Nephew Plc. (UK): COMPANY SNAPSHOT TABLE 34. Smith & Nephew Plc. (UK): OPERATING SEGMENTS TABLE 35. ARTHREX, INC. (US): COMPANY SNAPSHOT TABLE 36. ARTHREX, INC. (US): OPERATING SEGMENTS TABLE 37. STRYKER CORPORATION (US): COMPANY SNAPSHOT TABLE 38. STRYKER CORPORATION (US): OPERATING SEGMENTS TABLE 39. JOHNSON & JOHNSON (US) : COMPANY SNAPSHOT TABLE 40. JOHNSON & JOHNSON (US) : OPERATING SEGMENTS TABLE 41. MEDTRONIC PLC. (IE): COMPANY SNAPSHOT TABLE 42. MEDTRONIC PLC. (IE): OPERATING SEGMENTS TABLE 43. LifeNet Health, Inc. (US): COMPANY SNAPSHOT TABLE 44. LifeNet Health, Inc. (US): OPERATING SEGMENTS TABLE 45. Becton, Dickinson and Company (US): COMPANY SNAPSHOT TABLE 46. Becton, Dickinson and Company (US): OPERATING SEGMENTS TABLE 47. Integra LifeSciences Corporation (US): COMPANY SNAPSHOT TABLE 48. Integra LifeSciences Corporation (US): OPERATING SEGMENTS TABLE 49. CryoLife, Inc. (US): COMPANY SNAPSHOT TABLE 50. CryoLife, Inc. (US): OPERATING SEGMENTS TABLE 51. Organogenesis Inc. (US): COMPANY SNAPSHOT TABLE 52. Organogenesis Inc. (US): OPERATING SEGMENTS TABLE 53. Zimmer Biomet (US): COMPANY SNAPSHOT TABLE 54. Zimmer Biomet (US): OPERATING SEGMENTS TABLE 55. Baxter International, Inc. (US): COMPANY SNAPSHOT TABLE 56. Baxter International, Inc. (US): OPERATING SEGMENTS TABLE 57. ACell Inc. (US): COMPANY SNAPSHOT TABLE 58. ACell Inc. (US): OPERATING SEGMENTS TABLE 59. Tissue Regenix Group Plc (UK): COMPANY SNAPSHOT TABLE 60. Tissue Regenix Group Plc (UK): OPERATING SEGMENTS TABLE 61. AroaBiosurgery Ltd. (NZ): COMPANY SNAPSHOT TABLE 62. AroaBiosurgery Ltd. (NZ): OPERATING SEGMENTS TABLE 63. Orthofix Medical Inc. : COMPANY SNAPSHOT TABLE 64. Orthofix Medical Inc. : OPERATING SEGMENTS List of Figures (22 Figures) Figure 1 Market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries: Market Figure 4 Research Methodology: Hypothesis Building Figure 5 Market: Product-Based Estimation Figure 6 Top 16 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2020 Figure 8 Import Data for , By Country, 2016–2020 (USD Thousand) Figure 9 Export Data for , By Country, 2016–2020 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11 Market, By End-User, 2019 vs. 2025 (USD Million) Figure 12 Market Share, By Application, 2019 vs. 2025 (USD Million) Figure 13 Market Share, By Product, 2019 vs. 2025 (USD Million) Figure 14 Geographical Snapshot of the Market Figure 15 Tissue Patch/Mesh to Witness Higher CAGR in the Market for Product Segment during Forecast Period. Figure 16 Hernia repair to Witness Higher CAGR in the Market for Application Segment during Forecast Period. Figure 17 Hospital to Witness Higher CAGR in the Market for End-User Segment during Forecast Period. Figure 18 APAC region Accounted for the Largest Share of the Market, By Regional Basis, in 2019 Figure 19 Market: Drivers, Restraints, Opportunities, and Challenges Figure 20 North America: Market Snapshot Figure 21 Asia Pacific: Market Snapshot Figure 22 Vendor Dive: Evaluation Overview